Newsroom | 123755 results

DUBLIN--(BUSINESS WIRE)--The "Fluoroform (CAS 75-46-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering. This report on Fluoroform provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth study serves as a vital resource for understan...

MEUDON, France--(BUSINESS WIRE)--Thales a annoncé aujourd’hui les résultats de son 2025 Digital Trust Index - Consumer Edition, révélant un déclin à l’échelle mondiale de la confiance dans les services numériques par rapport à la même époque l’année dernière. Dans 13 secteurs différents, seuls l’assurance, la banque et le gouvernement ont vu leur niveau de confiance rester inchangé ou augmenter très légèrement. Lorsqu’il leur est demandé à quel secteur ils font le plus confiance pour leurs donn...

東京--(BUSINESS WIRE)--(美國商業資訊)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation（總部：東京昭島市；執行長：Jun Kawakami；以下簡稱「Rigaku」），與SPERA PHARMA, Inc.（總部：大阪市；董事長兼代表董事：Keitaro Iwaki；以下簡稱「SPERA PHARMA」）宣佈達成戰略合作，旨在通過整合雙方尖端技術與深厚專業知識，加速並革新藥物研發進程。 SPERA PHARMA將採用Rigaku提供的電子衍射集成平台XtaLAB Synergy-ED開展合約分析服務，為客戶的藥物研發提供強力支援。 XtaLAB Synergy-ED搭載的3D ED/MicroED1可用於物質結構分析，包括顯微晶體和微量結晶粉末。這項尖端技術具有足夠高的解析度，可以確定原子級結構，從而詳細闡明有機化合物及類似物質的分子結構。 SPERA PHARMA目前是全球醫藥行業唯一一家提供XtaLAB Synergy-ED合約分析服務的企業。Rigaku將為SPERA PHARMA的合約分析業務提供全面...

TULSA, Oklahoma.--(BUSINESS WIRE)--Spartan College of Aeronautics and Technology se enorgullece de anunciar su participación como expositor en la Feria Aeroespacial México (FAMEX) 2025 , que se realizará del 23 al 26 de abril en la Base Aérea Militar de Santa Lucía. Spartan invita a los aspirantes a profesionales de la aviación de México a analizar las oportunidades de capacitación con ellos en los EE.UU. Spartan College of Aeronautics and Technology fue fundada en 1928 y tiene una historia sum...

MELBOURNE, Fla.--(BUSINESS WIRE)--The Board of Directors of L3Harris Technologies (NYSE: LHX) has declared a quarterly cash dividend of $1.20 per common share, payable June 18, 2025, to shareholders of record as of the close of business on June 3, 2025. About L3Harris Technologies L3Harris Technologies is the Trusted Disruptor in the defense industry. With customers’ mission-critical needs always in mind, our employees deliver end-to-end technology solutions connecting the space, air, land, sea...

东京--(BUSINESS WIRE)--(美国商业资讯)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation（总部：东京昭岛市；首席执行官：Jun Kawakami；以下简称“Rigaku”），与SPERA PHARMA, Inc.（总部：大阪市；董事长兼代表董事：Keitaro Iwaki；以下简称“SPERA PHARMA”）宣布达成战略合作，旨在通过整合双方尖端技术与深厚专业知识，加速并革新药物研发进程。 SPERA PHARMA将采用Rigaku提供的电子衍射集成平台XtaLAB Synergy-ED开展合约分析服务，为客户的药物研发提供强力支持。 XtaLAB Synergy-ED搭载的3D ED/MicroED1可用于物质结构分析，包括显微晶体和微量结晶粉末。这项尖端技术具有足够高的分辨率，可以确定原子级结构，实现有机化合物和类似物质分子结构的精密阐明。 SPERA PHARMA目前是全球医药行业唯一一家提供XtaLAB Synergy-ED合约分析服务的企业。Rigaku将为SPERA PHARMA的合约分析业务提供...

ORLANDO, Fla.--(BUSINESS WIRE)--Beamer Laser Marking Systems (“Beamer” or “the Company”), a trusted U.S.-based provider of industrial fiber and CO2 laser marking equipment for high-precision applications, today announced an exciting new phase for the Company. Following its recent acquisition by Fonon Quantum Technologies, Inc. (FQTI), operations are now fully integrated into a state-of-the-art facility in Orlando, Fla. This transformative move positions Beamer for accelerated growth and continu...

LAGUNA HILLS, Calif.--(BUSINESS WIRE)--BrainChip Talks Corporate Remuneration on Latest Quarterly Investor Podcast...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend...

HERNDON, Va.--(BUSINESS WIRE)--BlackSky Technology Inc. (NYSE: BKSY) will host a conference call to discuss first quarter 2025 financial results and its business outlook on Thursday, May 8, 2025, at 8:30 a.m. EDT. A press release with BlackSky’s financial results will be released in advance of the conference call that same day. To access the live webcast or the archived webcast following completion of the call, please click here or visit the company’s investor relations website at http://ir.bla...